Teva Pharmaceutical Industries, Ltd.: Parkinson Disease trials
The registry lists 19 Parkinson Disease studies with Teva Pharmaceutical Industries, Ltd. as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 2Phase 2 2Phase 3 8Phase 4 3No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's DiseaseCompletedNCT01723228Phase 4Results posted
- Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's DiseaseCompletedNCT01049984Phase 4Results posted
- A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's DiseaseCompletedNCT00256204Phase 3Results posted
- Azilect® In Wearing-Off (AIWO)CompletedNCT02384512
- A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of RasagilineCompletedNCT01879748Phase 1
- Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's DiseaseCompletedNCT01032486
- Azilect + Antidepressant Chart ReviewCompletedNCT00955604
- ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease SubjectsCompletedNCT00936676
- Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric PropertiesCompletedNCT00932581
- A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's DiseaseCompletedNCT00399477Phase 4
- Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.CompletedNCT00203177Phase 3
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease PatientsCompletedNCT00203164Phase 3
- Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's DiseaseCompletedNCT00203138Phase 3
- A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.CompletedNCT00203125Phase 3
- Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With LevodopaCompletedNCT00203060Phase 3
- Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor FluctuationsCompletedNCT00203034Phase 3
- A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of MelanomaCompletedNCT00203008
- Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's DiseaseTerminatedNCT00040404Phase 2/3
- Effects of Talampanel on Patients With Advanced Parkinson's DiseaseCompletedNCT00036296Phase 1/2